Histone tail acetylation in brain occurs in an unpredictable fashion after death

Cell and Tissue Banking

Volumn 13, Issue 4, 2012, Pages 597-606

  Barrachina, Marta ^a,b   Moreno, Jesús ^a,b   Villar Menéndez, Izaskun ^a   Juvés, Salvador ^a,b   Ferrer, Isidre ^a,b,c  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Synuclein; Globin; ADORA2A; Histone acetylation; Post mortem delay; UCHL1

Indexed keywords

HISTONE;

ACETYLATION; AGED; ANIMAL; ARTICLE; AUTOPSY; BRAIN; CHEMISTRY; FEASIBILITY STUDY; GENETIC TRANSCRIPTION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; NUCLEOSOME; PHYSIOLOGY; PROTEIN PROCESSING; RAT; SPRAGUE DAWLEY RAT;

ACETYLATION; AGED; AGED, 80 AND OVER; ANIMALS; AUTOPSY; BRAIN; FEASIBILITY STUDIES; HISTONES; HUMANS; MALE; MIDDLE AGED; NUCLEOSOMES; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION, GENETIC;

EID: 84870296400     PISSN: 13899333     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10561-011-9278-9     Document Type: Article

References (51)

1. Alarcón JM, Malleret G, Touzani K et al (2004) Chromatin acetylation, memory, and LTP are impaired in CBP+/-mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration. Neuron 42:947-959
2. Allfrey VG, Faulkner R, Mirsky AE (1964) Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc Natl Acad Sci USA 51:786-794
3. Barrachina M, Ferrer I (2009) DNA methylation of Alzheimer disease and tauopathy-related genes in postmortem brain. J Neuropathol Exp Neurol 68:880-891
4. Barrachina M, Castaño E, Ferrer I (2006) TaqMan PCR assay in the control of RNA normalization in human post-mortem brain tissue. Neurochem Int 49:276-284
5. Barski A, Cuddapah S, Cui K et al (2007) High-resolution profiling of histone methylations in the human genome. Cell 129:823-837
6. Biagioli M, Pinto M, Cesselli D et al (2009) Unexpected expression of alpha- and beta-globin in mesencephalic dopaminergic neurons and glial cells. Proc Natl Acad Sci USA 106:15454-15459
7. Braak H, Alafuzoff I, Arzberger T et al (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389-404
8. Buesa C, Maes T, Subirada F et al (2004) DNA chip technology in brain banks: confronting a degrading world. J Neuropathol Exp Neurol 63:1003-1014
9. Butler R, Bates GP (2006) Histone deacetylase inhibitors as therapeutics for polyglutamine disorders. Nat Rev Neurosci 7:784-796
10. Calon F, Dridi M, Hornykiewicz O et al (2004) Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias. Brain 127:1075-1084
11. Cheung P, Allis CD, Sassone-Corsi P (2000) Signaling to chromatin through histone modifications. Cell 103:263-271
12. Chiba-Falek O, Touchman JW, Nussbaum RL (2003) Functional analysis of intra-allelic variation at NACP-Rep1 in the alpha-synuclein gene. Hum Genet 113:426-431
13. Crecelius A, Götz A, Arzberger T et al (2008) Assessing quantitative post-mortem changes in the gray matter of the human frontal cortex proteome by 2-D DIGE. Proteomics 8:1276-1291
14. De los Santos M, Zambrano A, Aranda A (2007) Combined effects of retinoic acid and histone deacetylase inhibitors on human neuroblastoma SH-SY5Y cells. Mol Cancer Ther 6:1425-1432
15. Durrenberger PF, Fernando S, Kashefi SN et al (2010) Effects of antemortem and postmortem variables on human brain mRNA quality: a BrainNet Europe study. J Neuropathol Exp Neurol 69:70-81
16. Faraco G, Pancani T, Formentini L et al (2006) Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain. Mol Pharmacol 70:1876-1884
17. Ferrer I, Armstrong J, Capellari S et al (2007a) Effects of formalin fixation, paraffin embedding, and time of storage on DNA preservation in brain tissue: a BrainNet Europe study. Brain Pathol 17:297-303
18. Ferrer I, Santpere G, Arzberger T et al (2007b) Brain protein preservation largely depends on the postmortem storage temperature: implications for study of proteins in human neurologic diseases and management of brain banks: a BrainNet Europe Study. J Neuropathol Exp Neurol 66: 35-46
19. Ferrer I, Martinez A, Boluda S et al (2008) Brain banks: benefits, limitations and cautions concerning the use of post-mortem brain tissue for molecular studies. Cell Tissue Bank 9:181-194
20. Fischer A, Sananbenesi F, Wang X et al (2007) Recovery of learning and memory is associated with chromatin remodelling. Nature 447:178-182
21. Forsberg EC, Downs KM, Christensen HM et al (2000) Developmentally dynamic histone acetylation pattern of a tissue-specific chromatin domain. Proc Natl Acad Sci USA 97:14494-14499
22. Fountoulakis M, Hardmeier R, Höger H et al (2001) Postmortem changes in the level of brain proteins. Exp Neurol 167:86-94
23. Govindarajan N, Agis-Balboa RC, Walter J et al (2011) Sodium butyrate improves memory function in an Alzheimer's disease mouse model when administered at an advanced stage of disease progression. J Alzheimers Dis May 13. [Epub ahead of print]
24. Guan JS, Haggarty SJ, Giacometti E et al (2009) HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 459:55-60
25. Hebbes TR, Thorne AW, Crane-Robinson C (1988) A direct link between core histone acetylation and transcriptionally active chromatin. EMBO J 7:1395-1402
26. Heintzman ND, Hon GC, Hawkins RD et al (2009) Histone modifications at human enhancers reflect global cell-typespecific gene expression. Nature 459:108-112
27. Herman D, Jenssen K, Burnett R et al (2006) Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. Nat Chem Biol 2:551-558
28. Hogarth P, Lovrecic L, Krainc D (2007) Sodium phenylbutyrate in Huntington's disease: a dose-finding study. Mov Disord 22:1962-1964
29. Huang HS, Matevossian A, Jiang Y (2006) Chromatin immunoprecipitation in postmortem brain. J Neurosci Methods 156:284-292
30. Hunsucker SW, Solomon B, Gawryluk J et al (2008) Assessment of post-mortem-induced changes to the mouse brain proteome. J Neurochem 105:725-737
31. Jenuwein T, Allis CD (2001) Translating the histone code. Science 293:1074-1080
32. Kretzschmar H (2009) Brain banking: opportunities, challenges and meaning for the future. Nat Rev Neurosci 10:70-78
33. Larsen CN, Krantz BA, Wilkinson KD (1998) Substrate specificity of de-ubiquitinating enzymes: ubiquitin C-terminal hydrolases. Biochemistry 37:3358-3368
34. Lee BM, Mahadevan LC (2009) Stability of histone modifications across mammalian genomes: implications for 'epigenetic' marking. J Cell Biochem 108:22-34
35. Levenson JM, O'Riordan KJ, Brown KD et al (2004) Regulation of histone acetylation during memory formation in the hippocampus. J Biol Chem 279:40545-40559
36. Luger K, Mäder AW, Richmond RK et al (1997) Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389:251-260
37. Monoranu CM, Grünblatt E, Bartl J et al (2010) Methyl- and acetyltransferases are stable epigenetic markers post-mortem. Cell Tissue Bank Jul 23 [Epub ahead of print]
38. Monti B, Gatta V, Piretti F et al (2010) Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha-synuclein. Neurotox Res 17:130-141
39. Peleg S, Sananbenesi F, Zovoilis A et al (2010) Altered histone acetylation is associated with age-dependent memory impairment in mice. Science 328:753-756
40. Ren M, Leng Y, Jeong M et al (2004) Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction. J Neurochem 89:1358-1367
41. Richter F, Meurers BH, Zhu C et al (2009) Neurons express hemoglobin alpha- and beta-chains in rat and human brains. J Comp Neurol 515:538-547
42. Ricobaraza A, Cuadrado-Tejedor M, Pérez-Mediavilla A (2009) Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model. Neuropsychopharmacology 34:1721-1732
43. Rosenfeld JA, Wang Z, Schones DE et al (2009) Determination of enriched histone modifications in non-genic portions of the human genome. BMC Genomics 10:143
44. Schnell S, Mendoza C (1997) Enzymological considerations for a theoretical description of the quantitative competitive polymerase chain reaction (QC-PCR). J Theor Biol 184:433-440
45. Sköld K, Svensson M, Norrman M et al (2007) The significance of biochemical and molecular sample integrity in brain proteomics and peptidomics: stathmin 2-20 and peptides as sample quality indicators. Proteomics 7:4445-4456
46. Solano SM, Miller DW, Augood SJ et al (2000) Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease. Ann Neurol 47:201-210
47. Stadler F, Kolb G, Rubusch L et al (2005) Histone methylation at gene promoters is associated with developmental regulation and region-specific expression of ionotropic and metabotropic glutamate receptors in human brain. J Neurochem 94:324-336
48. Strahl BD, Allis CD (2000) The language of covalent histone modifications. Nature 403:41-45
49. Touchman JW, Dehejia A, Chiba-Falek O et al (2001) Human and mouse alpha-synuclein genes: comparative genomic sequence analysis and identification of a novel gene regulatory element. Genome Res 11:78-86
50. Wang Z, Zang C, Rosenfeld JA et al (2008) Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 40:897-903
51. Zhao TC, Cheng G, Zhang LX et al (2007) Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury. Cardiovasc Res 76:473-481